The global apheresis market is expected to exceed US$ 3.5 billion by 2024, registering a compound annual growth rate (CAGR) of 11.5% during the forecast period. The growth of the market is attributed to factors such as the rising prevalence of diseases, growing number of trauma and injury cases, and increasing demand for source plasma from biopharmaceutical companies. In addition, the rising demand for blood components and growing concerns regarding blood safety, increase in the number of complex surgical procedures, and favorable reimbursement policies for apheresis procedures are expected to drive the market. However, the lack of awareness about apheresis procedures, the high cost of apheresis devices and procedure, and scarcity of qualified donors are hampering the growth of the market.
In this report, the global apheresis market is segmented by product, application, procedure, technology, and region. On the basis of product, the market is segmented into apheresis machine and disposable apheresis kits. The market on the basis of application is segmented into renal diseases, neurology, hematology, and others.
By procedure, the market is segmented into plasmapheresis, leukapheresis, LDL-apheresis, plateletpheresis, erythrocytapheresis, photopheresis, and others. The plasmapheresis segment accounts for the largest share of the market. However, the market in the photopheresis application is projected to register the highest CAGR during the forecast period.
The global apheresis market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, and Rest of the World. North America is the dominant apheresis market, whereas the market in Asia Pacific is expected to witness high growth during the forecast period. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional apheresis market and analyzes the variations in the growth of the industry in certain regions.
A glimpse of the report structure is provided in the report description available on the website.
Fresenius Kabi, Haemonetics, Terumo BCT, Therakos, Inc., Asahi Kasei Kuraray Medical Co Ltd, and B. Braun Melsungen AG are the most active players in the apheresis market.
This report covers the apheresis market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global apheresis market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
The deep-dive study on the apheresis market will help customers with identifications of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com